These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 33336414

  • 1. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
    Poston JN, Jash A, Hannan LM, Hay AM, Usaneerungrueng C, Howie HL, Kapp LM, Zimring JC.
    Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 5. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
    Semple JW, Speck ER, Cosgrave D, Lazarus AH, Blanchette VS, Freedman J.
    Blood; 1999 Jan 15; 93(2):713-20. PubMed ID: 9885234
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.
    Gilson CR, Zimring JC.
    Transfusion; 2012 Apr 15; 52(4):849-59. PubMed ID: 21981241
    [Abstract] [Full Text] [Related]

  • 12. Alloimmunization to platelets in heavily transfused patients with sickle cell disease.
    Friedman DF, Lukas MB, Jawad A, Larson PJ, Ohene-Frempong K, Manno CS.
    Blood; 1996 Oct 15; 88(8):3216-22. PubMed ID: 8874223
    [Abstract] [Full Text] [Related]

  • 13. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D.
    Rev Med Chil; 1997 Nov 15; 125(11):1305-12. PubMed ID: 9609051
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemia.
    Kekomäki S, Volin L, Koistinen P, Koivunen E, Koskimies S, Ruutu T, Timonen T, Kekomäki R.
    Eur J Haematol; 1998 Feb 15; 60(2):112-8. PubMed ID: 9508352
    [Abstract] [Full Text] [Related]

  • 15. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
    Panch SR, Guo L, Vassallo R.
    Blood Rev; 2023 Nov 15; 62():101135. PubMed ID: 37805287
    [Abstract] [Full Text] [Related]

  • 16. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J, Xia W, Deng J, Xu X, Shao Y, Ding H, Chen Y, Liu J, Chen D, Ye X, Santoso S.
    Transfus Med; 2018 Feb 15; 28(1):40-46. PubMed ID: 28516675
    [Abstract] [Full Text] [Related]

  • 17. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
    Muench MO, Heitman JW, Inglis H, Fomin ME, Marschner S, Goodrich RP, Norris PJ, Jackman RP.
    Transfusion; 2016 Jun 15; 56(6):1419-29. PubMed ID: 27028210
    [Abstract] [Full Text] [Related]

  • 18. Maternal immunization to Gov system alloantigens on human platelets.
    Bordin JO, Kelton JG, Warner MN, Smith JW, Denomme GA, Warkentin TE, McGrath K, Minchinton R, Hayward CP.
    Transfusion; 1997 Aug 15; 37(8):823-8. PubMed ID: 9280327
    [Abstract] [Full Text] [Related]

  • 19. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A.
    Blood; 1995 Feb 01; 85(3):824-8. PubMed ID: 7833483
    [Abstract] [Full Text] [Related]

  • 20. Clinical aspects of platelet transfusions.
    Murphy MF, Waters AH.
    Blood Coagul Fibrinolysis; 1991 Apr 01; 2(2):389-96. PubMed ID: 1893071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.